Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data
Author:
Publisher
Galenos Yayinevi
Subject
General Medicine
Reference15 articles.
1. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study;Union HCV Collaborators;Lancet Gastroenterol Hepatol,2017
2. 2. Zare F, Fattahi MR, Sepehrimanesh M, Safarpour AR. Economic Burden of Hepatitis C Virus Infection in Different Stages of Disease: A Report from Southern Iran. Hepat Mon. 2016;16(4):e32654.
3. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study;Tozun;Clin Microbiol Infect,2015
4. Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection;Koff;Aliment Pharmacol Ther,2014
5. Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment;Daniel;J Viral Hepat,2020
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Glecaprevir/pibrentasvir;Reactions Weekly;2024-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3